http://www.eurekalert.org/pub_releases/ ... 022812.php
"The scientific sessions at this year's Annual Scientific Meeting will include studies that highlight current research relating to the care of patients with cancer, peripheral arterial disease, stroke and venous disease and the potential role of treating chronic cerebrospinal venous insufficiency, or CCSVI, in patients with multiple sclerosis," noted Gary P. Siskin, M.D., FSIR, Annual Scientific Meeting scientific program chair.
Siskin will examine the pathophysiology of CCSVI (a blockage in the veins that drain blood from the brain and spinal cord and return it to the heart) and the factors supporting its consideration as a contributing factor in multiple sclerosis.